MedTrace Logo

Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants

NCT00127465 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2008-12-11

No results posted yet for this study

Summary

Objective: To explore the hypothesis that different methods of selecting and printing information for cancer patients could improve emotional support by affecting interaction with others, and so lead to improved psychological wellbeing.

Design: Randomised trial with 8 groups (three factors, 2X2X2). Data collected at recruitment and three month follow-up.

Participants: 400 patients starting radiotherapy and their 'confidant' (the person in who they confide).

Interventions: Printed booklets.

1. Half had 'general' CancerBACUP information for that cancer; half had 'personal' information from the medical record plus selected general information;
2. Half chose information by 'interacting' with the computer; half had a larger volume of material in booklets that were produced 'automatically'.
3. Half had additional 'anxiety management advice'.

Outcomes: Patients' views; use of booklet with others; change in reported social support; change in anxiety and depression.

Conditions

  • Breast Neoplasms
  • Prostatic Neoplasms
  • Laryngeal Neoplasms
  • Cervix Neoplasms

Interventions

PROCEDURE

Issue of information booklet

Sponsors & Collaborators

  • University of Plymouth

    lead OTHER

Principal Investigators

  • Ray Jones, PhD · University of Plymouth

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-11-30
Completion
2003-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00127465 on ClinicalTrials.gov